These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29108278)

  • 1. Epstein-Barr virus BRLF1 induces genomic instability and progressive malignancy in nasopharyngeal carcinoma cells.
    Huang SY; Wu CC; Cheng YJ; Chou SP; Jiang YJ; Chu KC; Tsai CH; Lin SF; Chen JY
    Oncotarget; 2017 Oct; 8(45):78948-78964. PubMed ID: 29108278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma.
    Chiu SH; Wu CC; Fang CY; Yu SL; Hsu HY; Chow YH; Chen JY
    Oncotarget; 2014 Sep; 5(18):8583-601. PubMed ID: 25261366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspective: Contribution of Epstein-Barr virus (EBV) Reactivation to the Carcinogenicity of Nasopharyngeal Cancer Cells.
    Wu CC; Fang CY; Huang SY; Chiu SH; Lee CH; Chen JY
    Cancers (Basel); 2018 Apr; 10(4):. PubMed ID: 29673164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent chemical reactivations of EBV promotes genome instability and enhances tumor progression of nasopharyngeal carcinoma cells.
    Fang CY; Lee CH; Wu CC; Chang YT; Yu SL; Chou SP; Huang PT; Chen CL; Hou JW; Chang Y; Tsai CH; Takada K; Chen JY
    Int J Cancer; 2009 May; 124(9):2016-25. PubMed ID: 19132751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear factor-Y and Epstein Barr virus in nasopharyngeal cancer.
    Chia MC; Leung A; Krushel T; Alajez NM; Lo KW; Busson P; Klamut HJ; Bastianutto C; Liu FF
    Clin Cancer Res; 2008 Feb; 14(4):984-94. PubMed ID: 18281530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-methyl-N'-nitro-N-nitrosoguanidine induces and cooperates with 12-O-tetradecanoylphorbol-1,3-acetate/sodium butyrate to enhance Epstein-Barr virus reactivation and genome instability in nasopharyngeal carcinoma cells.
    Huang SY; Fang CY; Tsai CH; Chang Y; Takada K; Hsu TY; Chen JY
    Chem Biol Interact; 2010 Dec; 188(3):623-34. PubMed ID: 20869957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus immediate-early protein BRLF1 induces the lytic form of viral replication through a mechanism involving phosphatidylinositol-3 kinase activation.
    Darr CD; Mauser A; Kenney S
    J Virol; 2001 Jul; 75(13):6135-42. PubMed ID: 11390615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive profiling of EBV gene expression in nasopharyngeal carcinoma through paired-end transcriptome sequencing.
    Hu L; Lin Z; Wu Y; Dong J; Zhao B; Cheng Y; Huang P; Xu L; Xia T; Xiong D; Wang H; Li M; Guo L; Kieff E; Zeng Y; Zhong Q; Zeng M
    Front Med; 2016 Mar; 10(1):61-75. PubMed ID: 26969667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters.
    Reusch JA; Nawandar DM; Wright KL; Kenney SC; Mertz JE
    J Virol; 2015 Feb; 89(3):1731-43. PubMed ID: 25410866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of nasopharyngeal carcinoma growth by RTA-expressing baculovirus vectors containing oriP.
    Wang L; Shan L; Lo KW; Yin J; Zhang Y; Sun R; Zhong J
    J Gene Med; 2008 Oct; 10(10):1124-33. PubMed ID: 18642396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of lytic Epstein-Barr virus (EBV) infection in EBV-associated malignancies using adenovirus vectors in vitro and in vivo.
    Westphal EM; Mauser A; Swenson J; Davis MG; Talarico CL; Kenney SC
    Cancer Res; 1999 Apr; 59(7):1485-91. PubMed ID: 10197618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualitative analysis of the expression of Epstein-Barr virus lytic genes in nasopharyngeal carcinoma biopsies.
    Martel-Renoir D; Grunewald V; Touitou R; Schwaab G; Joab I
    J Gen Virol; 1995 Jun; 76 ( Pt 6)():1401-8. PubMed ID: 7782768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus immediate-early protein BRLF1 interacts with CBP, promoting enhanced BRLF1 transactivation.
    Swenson JJ; Holley-Guthrie E; Kenney SC
    J Virol; 2001 Jul; 75(13):6228-34. PubMed ID: 11390628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation-induced Epstein-Barr virus reactivation in gastric cancer cells with latent EBV infection.
    Nandakumar A; Uwatoko F; Yamamoto M; Tomita K; Majima HJ; Akiba S; Koriyama C
    Tumour Biol; 2017 Jul; 39(7):1010428317717718. PubMed ID: 28675108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
    Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
    Ye J; Gradoville L; Daigle D; Miller G
    J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rescue of the Epstein-Barr virus BZLF1 mutant, Z(S186A), early gene activation defect by the BRLF1 gene product.
    Adamson AL; Kenney SC
    Virology; 1998 Nov; 251(1):187-97. PubMed ID: 9813214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Epstein-Barr virus infection on global gene expression in nasopharyngeal carcinoma.
    Lee YC; Hwang YC; Chen KC; Lin YS; Huang DY; Huang TW; Kao CY; Wu HC; Lin CT; Huang CY
    Funct Integr Genomics; 2007 Jan; 7(1):79-93. PubMed ID: 16988809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Structural and functional features of Epstein-Barr virus LMP-1 gene in patients with anaplastic carcinoma of the nasopharynx in Russia].
    Gurtsevich VE; Shcherbak LN; Novikova EV; Hahn P; Belousova NV; Arkhipov VV; Grasser FA; Müller-Lantzsch N; Pavlish OA
    Vestn Ross Akad Med Nauk; 2002; (1):53-9. PubMed ID: 11882974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of antibody against Epstein-Barr virus genes BRLF1 and BZLF1 in nasopharyngeal carcinoma.
    Yoshizaki T; Miwa H; Takeshita H; Sato H; Furukawa M
    J Cancer Res Clin Oncol; 2000 Feb; 126(2):69-73. PubMed ID: 10664244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.